Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.22) by 13.64 percent. This is a 18.75 percent decrease over losses of $(0.16) per share from the same period last year.
Morgan Stanley Maintains Underweight on Helmerich & Payne, Raises Price Target to $48
Morgan Stanley analyst Connor Lynagh maintains Helmerich & Payne (NYSE:HP) with a Underweight and raises the price target from $45 to $48.
